Dr. Lalchandani Labs Ltd.BSE: DLCL

Dr. Lalchandani Labs Ltd. Press Release Mar 05 2026

· Issued by Dr. Lalchandani Labs Ltd.

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anuraag Gambhir

View Attachment

Earlier from Dr. Lalchandani Labs

All Dr. Lalchandani Labs news releases